An analysis of spontaneous behavior following acute MDMA treatment in male and female rats

Neuroendocrinology Letters

Volumn 28, Issue 6, 2007, Pages 781-788

  Paleníček, Tomáš ^a   Hliňák, Zdeněk ^a   Bubeníková Valešová, Věra ^a   Votava, Martin ^b   Horáček, Jiří ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA); Behavior; Gender differences; Open field; Rats

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; DRUG EFFECT; FEMALE; GROOMING; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; RAT; SEX DIFFERENCE; SNIFFING; STEREOTYPY;

EID: 37849034699     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Antoniou K and Kafetzopoulos E (1991).A Comparative Study of the Behavioral Effects of D-Amphetamine and Apomorphine in the Rat. Pharmacol Biochem Behav. 39(1): 61-70.
2. Ball KT, Budreau D, and Rebec GV (2003).Acute Effects of 3,4-Methylenedioxymethamphetamine on Striatal Single-Unit Activity and Behavior in Freely Moving Rats: Differential Involvement of Dopamine D(1) and D(2) Receptors. Brain Res. 994(2): 203-15.
3. Bankson MG and Cunningham KA (2002).Pharmacological Studies of the Acute Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity: Role of 5-HT(1B/1D) and 5-HT(2) Receptors. Neuropsychophormacology. 26(1): 40-52.
4. Bubar MJ, Pack KM, Frankel PS, and Cunningham KA (2004).Effects of Dopamine D1- or D2-Like Receptor Antagonists on the Hypermotive and Discriminative Stimulus Effects of (+)-MDMA. Psychopharmacology (Berl). 173(3-4): 326-36.
5. Bubenikova V, Votava M, Horacek J, and Palenicek T (2005). Relation of Sex and Estrous Phase to Deficits in Prepulse Inhibition of the Startle Response Induced by Ecstasy (MDMA). Behav Pharmacol. 16(2): 127-30.
6. Callaway CW, Wing LL, and Geyer MA (1990).Serotonin Release Contributes to the Locomotor Stimulant Effects of 3,4-Methylenedioxymethamphetamine in Rats. J Pharmacol Exp Ther. 254(2): 456-64.
7. Chu T, Kumagai Y, DiStefano EW, and Cho AK (1996).Disposition of Methylenedioxymethamphetamine and Three Metabolites in the Brains of Different Rat Strains and Their Possible Roles in Acute Serotonin Depletion. Biochem Pharmacol. 51(6): 789-96.
8. Colado MI, Williams JL, and Green AR (1995).The Hyperthermic and Neurotoxic Effects of 'Ecstasy' (MDMA) and 3,4 Methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) Rat, a Model of the CYP2D6 Poor Metabolizer Phenotype. Br J Pharmacol. 115(7): 1281-9.
9. Fone KC, Beckett SR, Topham IA, Swettenham J, Ball M, and Maddocks L (2002).Long-Term Changes in Social Interaction and Reward Following Repeated MDMA Administration to Adolescent Rats Without Accompanying Serotonergic Neurotoxicity. Psychopharmacology (Berl). 159(4): 437-44.
10. Gold LH, Geyer MA, and Koob GF (1989).Neurochemical Mechanisms Involved in Behavioral Effects of Amphetamines and Related Designer Drugs. NIDA Res Monogr. 94: 101-26.
11. Green AR, Cross AJ, and Goodwin GM (1995).Review of the Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology (Berl). 119(3): 247-60.
12. Ho YJ, Pawlak CR, Guo L, and Schwarting RK (2004).Acute and Long-Term Consequences of Single MDMA Administration in Relation to Individual Anxiety Levels in the Rat. Behav Brain Res. 149(2): 135-44.
13. Koenig J, Lazarus C, Jeltsch H, Ben Hamida S, Riegert C, Kelche C, Jones BC, and Cassel JC (2005).MDMA (Ecstasy) Effects in Pubescent Rats: Males Are More Sensitive Than Females. Pharmacol Biochem Behav. 81(3): 635-44.
14. Landry MJ (2002).MDMA: a Review of Epidemiologic Data. J Psychoactive Drugs. 34(2): 163-9.
15. Liechti ME, Gamma A, and Vollenweider FX (2001).Gender Differences in the Subjective Effects of MDMA. Psychopharmacology (Berl). 154(2): 161-8.
16. Marona-Lewicka D and Nichols DE (1994).Behavioral Effects of the Highly Selective Serotonin Releasing Agent 5-Methoxy-6-Methyl-2-Aminoindan. Eur J Pharmacol. 258(1-2): 1-13.
17. McCann UD, Ridenour A, Shaham Y, and Ricaurte GA (1994).Serotonin Neurotoxicity After (+/-)3,4-Methylenedioxymethamphetamine (MDMA; "Ecstasy"): a Controlled Study in Humans. Neuropsychopharmacology. 10(2): 129-38.
18. McCreary AC, Bankson MG, and Cunningham KA (1999).Pharmacological Studies of the Acute and Chronic Effects of (+)-3, 4-Methylenedioxymethamphetamine on Locomotor Activity: Role of 5-Hydroxytryptamine(1A) and 5-Hydroxytryptamine(1B/1D) Receptors. J Pharmacol Exp Ther. 290(3): 965-73.
19. Milani RM, Parrott AC, Turner JJ, and Fox HC (2004).Gender Differences in Self-Reported Anxiety, Depression, and Somatization Among Ecstasy/ MDMA Polydrug Users, Alcohol/Tobacco Users, and Nondrug Users. Addict Behav. 29(5): 965-71.
20. Miller DB and O'Callaghan JP (1995).The Role of Temperature, Stress, and Other Factors in the Neurotoxicity of the Substituted Amphetamines 3,4-Methylenedioxymethamphetamine and Fenfluramine. Mol Neurobiol. 11(1-3): 177-92.
21. Nichols DE and Oberlender R (1990).Structure-Activity Relationships of MDMA and Related Compounds: a New Class of Psychoactive Drugs? Ann N Y Acad Sci. 600: 613-23.
22. O'Loinsigh ED, Boland G, Kelly JP, and O'Boyle KM (2001).Behavioural, Hyperthermic and Neurotoxic Effects of 3,4-Methylenedioxymethamphetamine Analogues in the Wistar Rat. Prog Neuropsychopharmacol Biol Psychiatry. 25(3): 621-38.
23. Palenicek T, Votava M, Bubenikova V, and Horacek J (2005).Increased Sensitivity to the Acute Effects of MDMA ("Ecstasy") in Female Rats. Physiol Behav. 86(4): 546-53.
24. Paulus MP and Geyer MA (1992).The Effects of MDMA and Other Methylenedioxy-Substituted Phenylalkylamines on the Structure of Rat Locomotor Activity. Neuropsychopharmacology. 7(1): 15-31.
25. Pranzatelli MR, Gantner C, and Snodgrass SR (1987).3-Acetylpyridine Lesions and Four Serotonergic Behavioral Syndromes in the Rat. Brain Res Bull. 18(2): 159-63.
26. Reneman L, Booij J, De Bruin K, Reitsma JB, de Wolff FA, Gunning WB, Den Heeten GJ, and Van Den BW (2001).Effects of Dose, Sex, and Long-Term Abstention From Use on Toxic Effects of MDMA (Ecstasy) on Brain Serotonin Neurons. Lancet. 358(9296): 1864-9.
27. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, and Parrott AC (2003).Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: a Web-Based Study. J Psychopharmacol. 17(4): 389-96.
28. Scearce-Levie K, Viswanathan SS, and Hen R (1999).Locomotor Response to MDMA Is Attenuated in Knockout Mice Lacking the 5-HT1B Receptor. Psychopharmacology (Berl). 141(2): 154-61.
29. Slikker W, Jr., Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, and Scalzo FM (1989).Behavioral and Neurochemical Effects of Orally Administered MDMA in the Rodent and Nonhuman Primate. Neurotoxicology. 10(3): 529-42.
30. Spanos LJ and Yamamoto BK (1989).Acute and Subchronic Effects of Methylenedioxymethamphetamine ((+/-)MDMA) on Locomotion and Serotonin Syndrome Behavior in the Rat. Pharmacol Biochem Behav. 32(4): 835-40.
31. Tossmann P, Boldt S, and Tensil MD (2001).The Use of Drugs Within the Techno Party Scene in European Metropolitan Cities. Eur Addict Res. 7(1): 2-23.
32. Verheyden SL, Hadfield J, Calin T, and Curran HV (2002).Sub-Acute Effects of MDMA (+/-3,4-Methylenedioxymethamphetamine, "Ecstasy") on Mood: Evidence of Gender Differences. Psychopharmacology (Berl). 161(1): 23-31.